February 24, 2009 - BrachySciences, a provider of medical devices for the treatment of early stage prostate cancer, has signed a distribution agreement with IsoRay Inc. to distribute manufacturer of Proxcelan, making BrachySciences the only provider of all three radioactive isotopes used in low dose rate (LDR) prostate brachytherapy.

IsoRay’s Cesium-131 is the only radioactive source available for brachytherapy. BrachySciences has added Cesium-131 source to its distribution portfolio of Advantage Iodine-125 and the TheraSeed Palladium-103 device.

With access to all three isotopes and a diverse brachytherapy product portfolio capable of satisfying any pre-planned or real-time implant technique, BrachySciences has the ability to function as a solitary vendor and complete service provider to hospitals and clinics with LDR implant programs.

For more information: brachysciences.com

Related Content

News | Brachytherapy Systems

August 31, 2021 — iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy ...

Time August 31, 2021
arrow
News | Radiation Oncology

June 2, 2021 — A breast cancer therapy that requires just one shot of radiotherapy is as effective as traditional ...

Time June 02, 2021
arrow
News | Brachytherapy Systems, Women's Healthcare

May 19, 2021 — A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells ...

Time May 19, 2021
arrow
Feature | Radiation Oncology | By Vinay Shivaprasad

The term nuclear medicine is associated with the diagnostic procedures single-photon emission computed tomography (SPECT ...

Time May 04, 2021
arrow
News | Brachytherapy Systems

December 29, 2020 — RaySearch Laboratories AB has launched the latest release of its widely adopted treatment planning ...

Time December 29, 2020
arrow
News | Prostate Cancer

October 30, 2020 — Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR) ...

Time October 30, 2020
arrow
News | Brachytherapy Systems

October 26, 2020 — iCAD, Inc. announced the Company will showcase the expanded platform for the Xoft Axxent Electronic ...

Time October 26, 2020
arrow
News | Brachytherapy Systems, Women's Healthcare

September 8, 2020 — Advanced Radiation Therapy has completed the installation of the AccuBoost Digital platform at the ...

Time September 08, 2020
arrow
News | Brachytherapy Systems

May 19, 2020 — iCAD, Inc. announced positive new clinical data supporting the Xoft Axxent Electronic Brachytherapy (eBx) ...

Time May 19, 2020
arrow
Sponsored Content | Videos | Artificial Intelligence

In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial ...

Time February 21, 2020
arrow
Subscribe Now